By vgreene, 21 January, 2021 Efficacy and Safety of Umifenovir for Coronavirus Disease 2019 COVID 19 A Systematic Review and Meta analysis access J Med Virol article
By vgreene, 21 January, 2021 However after emergency authorization distribution of the vaccines in the U K U S reports emerged of severe allergic rxns anaphylaxis polyethylene glycol is currently suspected as the cause of such rxns
By vgreene, 20 January, 2021 systemic sx approx 55 83 of vaccinated persons developed 1 systemic sx following vaccination
By vgreene, 20 January, 2021 systemic sx approx 55 83 of vaccinated persons developed 1 systemic sx following vaccination
By vgreene, 19 January, 2021 Encourage pts to enroll in CDC s VaxText SM a free text message based platform to receive COVID 19 vaccination 2nd dose reminders as well as the smartphone tool v safe that allows for personal check ins following vaccination1
By vgreene, 19 January, 2021 Although 2nd doses should be administered as close to the recommended interval 21 days apart for the Pfizer BioNTech vaccine 28 days apart for the Moderna vaccine if this isn t possible 2nd doses can be given up to 6wk 42 days after 1st dose w o having to
By vgreene, 19 January, 2021 Pts shouldn t be scheduled to receive their 2nd doses earlier than recommended 21 days apart for Pfizer BioNTech 28 days apart for Moderna However 2nd doses given w in a grace period of 4 days earlier than recommended are still considered valid Second dos
By vgreene, 19 January, 2021 Pts should complete their vaccine series w the same product as their first dose the Pfizer BioNTech Moderna vaccines aren t interchangeable 1 3 however CDC allows that in exceptional situations eg provider can t determine which vaccine the pt received the
By vgreene, 19 January, 2021 CDC currently recommends against additional booster doses beyond the 2 dose primary series1 unless individuals are moderately to severely immunocompromised
